PMID: 11329102May 1, 2001Paper

T-channel-selective calcium channel blockade: a promising therapeutic possibility, only preliminarily tested so far: a review of published data. T-Channel Calcium Channel Blocker Study Group

American Journal of Therapeutics
J A Van der VringM G Niemeyer

Abstract

Basic studies as well as short-term clinical trials of the T-channel-selective calcium channel blocker, mibefradil, are reviewed. The compound reduced afterload and was effective for the symptomatic treatment of hypertension and stable angina pectoris. It did not display any relevant negative inotropic or positive chronotropic effect. Mibefradil has been withdrawn by the manufacturer because of drug interaction at the cytochrome P-450 3A4 enzyme. It is hoped that new T-channel-selective calcium channel blockers will be developed to explore further this promising but so far only preliminarily tested therapeutic possibility.

Citations

Feb 19, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Min-Chul ShinNorio Akaike
Apr 20, 2004·Assay and Drug Development Technologies·David J Triggle
Jan 11, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jean-Marc IsraelStéphane H R Oliet
Nov 23, 2010·Expert Opinion on Therapeutic Patents·Fabrizio GiordanettoAndreas Wållberg
Apr 13, 2010·Bioorganic & Medicinal Chemistry Letters·Su Jin GuYong Seo Cho
Feb 4, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ivana Y KuoCaryl E Hill
Sep 18, 2007·Bioorganic & Medicinal Chemistry Letters·Han Na SeoJae Yeol Lee
Nov 17, 2004·British Journal of Pharmacology·Taiji FurukawaToshihide Nukada
Jul 26, 2011·Bioorganic & Medicinal Chemistry Letters·Fabrizio GiordanettoGöran Duker
Nov 19, 2005·Journal of Pharmacological Sciences·Hikaru Tanaka, Koki Shigenobu
Jul 16, 2008·Bioorganic & Medicinal Chemistry Letters·Hyung Kook LeeKye Jung Shin
Jul 11, 2002·American Journal of Physiology. Cell Physiology·Timothy D ArdizzoneDonard S Dwyer
Aug 5, 2010·The Journal of Pharmacology and Experimental Therapeutics·Richard L KrausJohn J Renger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.